• 1022 Citations
  • 17 h-Index
20072020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Turrent Robert Nakayama is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 1022 Citations
  • 17 h-Index
  • 55 Article
  • 2 Review article
  • 1 Comment/debate

A multidisciplinary approach to soft-tissue sarcoma of the extremities

Nakayama, R., Mori, T., Okita, Y., Shiraishi, Y. & Endo, M., 2020, (Accepted/In press) In : Expert Review of Anticancer Therapy.

Research output: Contribution to journalReview article

  • Feasibility of targeting traf2-and-nck-interacting kinase in synovial sarcoma

    Sekita, T., Yamada, T., Kobayashi, E., Yoshida, A., Hirozane, T., Kawai, A., Uno, Y., Moriyama, H., Sawa, M., Nagakawa, Y., Tsuchida, A., Matsumoto, M., Nakamura, M., Nakayama, R. & Masuda, M., 2020 May, In : Cancers. 12, 5, 1258.

    Research output: Contribution to journalArticle

    Open Access
  • Fibro-adipose vascular anomaly (FAVA): Three case reports with an emphasis on the mammalian target of rapamycin (mTOR) pathway

    Hori, Y., Hirose, K., Aramaki-Hattori, N., Suzuki, S., Nakayama, R., Inoue, M., Matsui, T., Kohara, M., Toyosawa, S. & Morii, E., 2020 Jul 25, In : Diagnostic Pathology. 15, 1, 98.

    Research output: Contribution to journalArticle

    Open Access
  • Phase II clinical trial of pazopanib for patients with unresectable or metastatic malignant peripheral nerve sheath tumors

    Nishida, Y., Urakawa, H., Nakayama, R., Kobayashi, E., Ozaki, T., Ae, K., Matsumoto, Y., Tsuchiya, H., Goto, T., Hiraga, H., Naka, N., Takahashi, S., Ando, Y., Ando, M., Kuwatsuka, Y., Hamada, S., Ueda, T. & Kawai, A., 2020, (Accepted/In press) In : International Journal of Cancer.

    Research output: Contribution to journalArticle

  • Phase II trial of pazopanib in patients with metastatic or unresectable chemoresistant sarcomas: A Japanese Musculoskeletal Oncology Group study

    Urakawa, H., Kawai, A., Goto, T., Hiraga, H., Ozaki, T., Tsuchiya, H., Nakayama, R., Naka, N., Matsumoto, Y., Kobayashi, E., Okuma, T., Kunisada, T., Ando, M., Ueda, T. & Nishida, Y., 2020 Sep 1, In : Cancer science. 111, 9, p. 3303-3312 10 p.

    Research output: Contribution to journalArticle

    Open Access